These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18706972)

  • 1. Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype.
    Mancuso M; Kiferle L; Petrozzi L; Nesti C; Rocchi A; Ceravolo R; Orsucci D; Maluccio MR; Bonuccelli U; Filosto M; Siciliano G; Murri L
    Neurosci Lett; 2008 Oct; 444(1):83-6. PubMed ID: 18706972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?
    Mancuso M; Conforti FL; Rocchi A; Tessitore A; Muglia M; Tedeschi G; Panza D; Monsurrò M; Sola P; Mandrioli J; Choub A; DelCorona A; Manca ML; Mazzei R; Sprovieri T; Filosto M; Salviati A; Valentino P; Bono F; Caracciolo M; Simone IL; La Bella V; Majorana G; Siciliano G; Murri L; Quattrone A
    Neurosci Lett; 2004 Nov; 371(2-3):158-62. PubMed ID: 15519748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population.
    Niemi AK; Hervonen A; Hurme M; Karhunen PJ; Jylhä M; Majamaa K
    Hum Genet; 2003 Jan; 112(1):29-33. PubMed ID: 12483296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis.
    Rego-Pérez I; Fernández-Moreno M; Fernández-López C; Arenas J; Blanco FJ
    Arthritis Rheum; 2008 Aug; 58(8):2387-96. PubMed ID: 18668590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H.
    Palacín M; Alvarez V; Martín M; Díaz M; Corao AI; Alonso B; Díaz-Molina B; Lozano I; Avanzas P; Morís C; Reguero JR; Rodríguez I; López-Larrea C; Cannata-Andía J; Batalla A; Ruiz-Ortega M; Martínez-Camblor P; Coto E
    Mitochondrion; 2011 Jan; 11(1):176-81. PubMed ID: 20863902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hOGG1 Ser326Cys polymorphism and Huntington's disease.
    Coppedè F; Migheli F; Ceravolo R; Bregant E; Rocchi A; Petrozzi L; Unti E; Lonigro R; Siciliano G; Migliore L
    Toxicology; 2010 Dec; 278(2):199-203. PubMed ID: 19857538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical features of the mitochondrial m.1555A>G mutation in Taiwanese patients with idiopathic sensorineural hearing loss and association of haplogroup F with low penetrance in three families.
    Wu CC; Chiu YH; Chen PJ; Hsu CJ
    Ear Hear; 2007 Jun; 28(3):332-42. PubMed ID: 17485982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial haplogroup H and Alzheimer's disease--is there a connection?
    Maruszak A; Canter JA; Styczyńska M; Zekanowski C; Barcikowska M
    Neurobiol Aging; 2009 Nov; 30(11):1749-55. PubMed ID: 18308428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany.
    Mancuso M; Nardini M; Micheli D; Rocchi A; Nesti C; Giglioli NJ; Petrozzi L; Rossi C; Ceravolo R; Bacci A; Choub A; Ricci G; Tognoni G; Manca ML; Siciliano G; Murri L
    Neurol Sci; 2007 Jun; 28(3):142-7. PubMed ID: 17603766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients.
    Swerdlow RH; Parks JK; Cassarino DS; Shilling AT; Bennett JP; Harrison MB; Parker WD
    Biochem Biophys Res Commun; 1999 Aug; 261(3):701-4. PubMed ID: 10441489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy.
    Nasi M; Guaraldi G; Orlando G; Durante C; Pinti M; Nemes E; Nardini G; Passarino G; Cocchi M; Esposito R; Mussini C; Cossarizza A
    Clin Infect Dis; 2008 Oct; 47(7):962-8. PubMed ID: 18752438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA haplogroups may influence Fabry disease phenotype.
    Simoncini C; Chico L; Concolino D; Sestito S; Fancellu L; Boadu W; Sechi GP; Feliciani C; Gnarra M; Zampetti A; Salviati A; Scarpelli M; Orsucci D; Bonuccelli U; Siciliano G; Mancuso M
    Neurosci Lett; 2016 Aug; 629():58-61. PubMed ID: 27365132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
    Panzera R; Salomonczyk D; Pirogovosky E; Simmons R; Goldstein J; Corey-Bloom J; Gilbert PE
    Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial haplogroups associated with elite Kenyan athlete status.
    Scott RA; Fuku N; Onywera VO; Boit M; Wilson RH; Tanaka M; H Goodwin W; Pitsiladis YP
    Med Sci Sports Exerc; 2009 Jan; 41(1):123-8. PubMed ID: 19092698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAG mutation effect on rate of progression in Huntington's disease.
    Squitieri F; Cannella M; Simonelli M
    Neurol Sci; 2002 Sep; 23 Suppl 2():S107-8. PubMed ID: 12548366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patients.
    Gallardo ME; García-Pavía P; Chamorro R; Vázquez ME; Gómez-Bueno M; Millán I; Almoguera B; Domingo V; Segovia J; Vilches C; Alonso-Pulpón L; Garesse R; Bornstein B
    Eur Heart J; 2012 Feb; 33(3):346-53. PubMed ID: 21821846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
    Vassos E; Panas M; Kladi A; Vassilopoulos D
    J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of complex movements reflects dysfunction in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    J Neurol; 2003 Dec; 250(12):1469-74. PubMed ID: 14673581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.